Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Conklin

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Lupus Science & Medicine|February 13, 2016
Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation productsDaniel J Wallace, Stuart L Silverman, John Conklin, et al.
Magnetic Resonance Imaging Clinics of North America|August 22, 2022
Emerging Techniques and Future Directions: Fast and Portable Magnetic Resonance ImagingMin Lang, Otto Rapalino, Susie Huang, et al.
Journal of Immunology Research|February 22, 2018
Performance Characteristics of Different Anti-Double-Stranded DNA Antibody Assays in the Monitoring of Systemic Lupus ErythematosusMichael Mahler, Chelsea Bentow, Tyler O'Malley, et al.
Lupus Science & Medicine|July 13, 2021
A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosusRoberta Vezza Alexander, Daniel Scott Rey, John Conklin, et al.
Lupus Science & Medicine|October 19, 2016
Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosusJill Buyon, Richard Furie, Chaim Putterman, et al.
Journal of Neuro-Oncology|July 5, 2017
Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathologyJay S Detsky, Julia Keith, John Conklin, et al.
AJR. American Journal of Roentgenology|August 7, 2020
Predictors of Anesthetic Exposure in Pediatric MRIFedel Machado-Rivas, Ellen Leitman, Camilo Jaimes, et al.
Journal of Immunological Methods|April 9, 2017
Validation of a multi-analyte panel with cell-bound complement activation products for systemic lupus erythematosusThierry Dervieux, John Conklin, Jo-Anne Ligayon, et al.
AJNR. American Journal of Neuroradiology|January 30, 2026
Clinical Validation of Deep Learning-Accelerated versus Wave-CAIPI Postcontrast 3D T1-MPRAGE for Evaluation of Intracranial Enhancing LesionsAzadeh Tabari, Maryam Vejdani-Jahromi, Min Lang, et al.
Lupus Science & Medicine|February 9, 2023
Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)John Conklin, Michael Golpanian, Alexis Engel, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Lupus Science & Medicine|February 13, 2016
Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation productsDaniel J Wallace, Stuart L Silverman, John Conklin, et al.
Magnetic Resonance Imaging Clinics of North America|August 22, 2022
Emerging Techniques and Future Directions: Fast and Portable Magnetic Resonance ImagingMin Lang, Otto Rapalino, Susie Huang, et al.
Journal of Immunology Research|February 22, 2018
Performance Characteristics of Different Anti-Double-Stranded DNA Antibody Assays in the Monitoring of Systemic Lupus ErythematosusMichael Mahler, Chelsea Bentow, Tyler O'Malley, et al.
Lupus Science & Medicine|July 13, 2021
A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosusRoberta Vezza Alexander, Daniel Scott Rey, John Conklin, et al.
Lupus Science & Medicine|October 19, 2016
Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosusJill Buyon, Richard Furie, Chaim Putterman, et al.
Journal of Neuro-Oncology|July 5, 2017
Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathologyJay S Detsky, Julia Keith, John Conklin, et al.
AJR. American Journal of Roentgenology|August 7, 2020
Predictors of Anesthetic Exposure in Pediatric MRIFedel Machado-Rivas, Ellen Leitman, Camilo Jaimes, et al.
Journal of Immunological Methods|April 9, 2017
Validation of a multi-analyte panel with cell-bound complement activation products for systemic lupus erythematosusThierry Dervieux, John Conklin, Jo-Anne Ligayon, et al.
AJNR. American Journal of Neuroradiology|January 30, 2026
Clinical Validation of Deep Learning-Accelerated versus Wave-CAIPI Postcontrast 3D T1-MPRAGE for Evaluation of Intracranial Enhancing LesionsAzadeh Tabari, Maryam Vejdani-Jahromi, Min Lang, et al.
Lupus Science & Medicine|February 9, 2023
Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)John Conklin, Michael Golpanian, Alexis Engel, et al.
Pageof 8